IPC Classification

All sections
A - Human necessities
A61K - Preparations for medical, dental or toiletry purposes
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans

Patent holdings for IPC class A61K 38/17

1205	1434	1453	1385	1525	1488	1309	1260	1168	372
2017	2018	2019	2020	2021	2022	2023	2024	2025	2026

Owner	All patents	This class
The Regents of the University of California	20574	355
The Board of Trustees of the Leland Stanford Junior University	6600	200
Immatics Biotechnologies GmbH	1117	153
Inserm (institut National de La Sante et de La Recherche Medicale)	3333	146
Regeneron Pharmaceuticals, Inc.	4618	145
The Trustees of the University of Pennsylvania	4406	139
Acceleron Pharma Inc.	342	134
Centre National de La Recherche Scientifique	10886	121
The United States of America, as represented by the Secretary, Department of Health and Human Services	2973	118
The General Hospital Corporation	4827	106
Dana-Farber Cancer Institute, Inc.	2648	106
The Johns Hopkins University	5825	105
President and Fellows of Harvard College	6045	98
Institut National de La Sante et de La Recherche Medicale (inserm)	3144	97
Board of Regents, The University of Texas System	6050	95
Novartis AG	10327	92
Children's Medical Center Corporation	1930	91
Modernatx, Inc.	1281	83
The Brigham and Women's Hospital, Inc.	2270	79
The Trustees of Columbia University in the City of New York	3633	69
Other owners		15429